Overview and Scope
Barrett’s esophagus is the medical term for a condition in which acid reflux harms the flat pink lining of the swallowing tube, which connects the mouth to the stomach. This affects the lining, causing it to thicken and turn red. Barrett’s esophagus is more resistant to stomach acid than squamous cells and intestinal cells, indicating that tissue alterations take place to shield the esophagus from acid exposure. This illness affects men more often than women and white people.
Sizing and Forecast
The barrett’s esophagus market size has grown strongly in recent years. It will grow from $5.98 billion in 2023 to $6.33 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of gastroesophageal reflux disease (gerd), aging population, increased awareness and screening programs, obesity epidemic, tobacco and alcohol consumption.
The barrett’s esophagus market size is expected to see strong growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to genetic and molecular research, personalized medicine approaches, increased focus on early detection, rising global healthcare expenditure, integration of artificial intelligence (ai). Major trends in the forecast period include collaborative research initiatives, innovations in endoscopic technologies, advancements in diagnostic technologies, integration of patient registries, lifestyle modification programs.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/barretts-esophagus-global-market-report
Segmentation & Regional Insights
The barrett’s esophagus market covered in this report is segmented –
1) By Type: No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types
2) By Treatment: Medication, Endoscopic Therapy, Surgery, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Rectal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
North America was the largest region in the barrett esophagus market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the barrett’s esophagus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=11990&type=smp
Major Driver Impacting Market Growth
Increased chances of esophageal cancer are expected to propel the growth of barrett esophagus market going forward. Esophageal cancer refers to a type of cancer that affects the esophagus, a long, hollow tube that connects the throat to the stomach. The rise in esophageal cancer occurs in patients with Barrett’s esophagus with dysplasia. However, the chance of developing esophageal cancer is higher in people with high-grade dysplasia in Barrett’s esophagus. For instance, in 2023, according to the American Cancer Society, a US-based cancer-fighting organization that provides patient support, research, and advocacy for cancer care, esophageal cancer will affect an estimated 21,560 people in 2023, compared to 20,640 people affected in 2022. Therefore, an increase in the chance of esophageal cancer is driving the growth of barrett esophagus market.
Key Industry Players
Major companies operating in the barrett’s esophagus market report are F Hoffmann-La Roche Ltd., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC., Merck KGaA, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, AdventHealth Medical Group, Olympus Corporation, Eisai Co. Ltd., Steris PLC, Aurobindo Pharma Limited, Cook Medical Inc., Endo International PLC, Sun Pharmaceutical Industries Limited, Ironwood Pharmaceuticals Inc., Spectrum Health System, Sebela Pharmaceuticals Inc., Phathom Pharmaceuticals Inc., EndoGastric Solutions Inc., NinePoint Medical Inc., Mederi Therapeutics Inc., SRS Pharmaceuticals Pvt. Ltd., Pinnacle Biologics Inc., Addex Therapeutics Ltd., Johnson & Johnson Private Limited, SpectraScience Inc., Zydus Group
The barrett’s esophagus market report table of contents includes:
1. Executive Summary
2. Barrett’s Esophagus Market Characteristics
3. Barrett’s Esophagus Market Trends And Strategies
4. Barrett’s Esophagus Market – Macro Economic Scenario
5. Global Barrett’s Esophagus Market Size and Growth
.
.
.
31. Barrett’s Esophagus Market Other Major And Innovative Companies
32. Global Barrett’s Esophagus Market Competitive Benchmarking
33. Global Barrett’s Esophagus Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Barrett’s Esophagus Market
35. Barrett’s Esophagus Market Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
